Clinical Impacts and Risk Factors for Central Line-Associated Bloodstream Infection: A Systematic Review.

Autor:	Alshahrani KM; Department of Internal Medicine, Aseer Central Hospital, Abha, SAU., Alhuwaishel AZ; Department of Internal Medicine, King Fahad Medical City, Riyadh, SAU., Alangari NM; Department of Internal Medicine, Aseer Central Hospital, Abha, SAU., Asiri MA; Department of Internal Medicine, Aseer Central Hospital, Abha, SAU., Al-Shahrani NA; Department of Internal Medicine, Armed Forces Hospital Southern Region, Khamis Mushait, SAU., Alasmari AA; Department of Internal Medicine, Aseer Central Hospital, Abha, SAU., Alzahrani OJ; Department of Internal Medicine, Aseer Central Hospital, Abha, SAU., Ayedh AY; Department of Internal Medicine, Aseer Central Hospital, Abha, SAU., Qitmah MM; Department of Internal Medicine, King Fahad Specialized Hospital, Tabouk, SAU.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2023 Jun 25; Vol. 15 (6), pp. e40954. Date of Electronic Publication: 2023 Jun 25 (Print Publication: 2023).
DOI:	10.7759/cureus.40954
Abstrakt:	Background A central line-associated bloodstream infection (CLABSI) is defined as a primary bloodstream infection (BSI) in a patient that had a central line within the 48-hour period before the development of the BSI and is not bloodstream-related to an infection at another site. CLABSI is a common healthcare-associated infection and a significant cause of morbidity and mortality. Methods This systematic review included studies published within the past 13 years that examined risk factors and clinical impact variables associated with CLABSI, using the Centers for Disease Control (CDC)/National Healthcare Safety Network (NHSN) criteria for defining catheter-associated infection, and included participants of all ages. The terms "CLABSI," "central line-associated bloodstream infection," "risk factors," "predictors," "morbidity," "mortality," "healthcare costs," and "length of hospital stay" were used to find relevant publications on PubMed/Medline, Google Scholar, and Science Direct. The quality assessment of the included publications utilized the modified Newcastle-Ottawa scale (NOS) for observational studies. Results After the full-text screening, we identified 15 articles that met our inclusion and exclusion criteria. The majority of these studies were of good quality and had a low risk of bias based on our bias assessment. The studies included a total of 32,198 participants and covered a time period from 2010 to 2023. The mean age of the male patients included in the studies ranged from 0.1 months to 69.1 years. All of the included studies were either observational cohort studies, cross sectional studies, case-control studies, or case reports. The major study parameters/outcomes extracted were risk factors, CLABSI-associated mortality, hospital cost, length of hospital stay, and catheter days. With respect to predisposing factors, multilumen access catheters were identified as risk factors in three studies, use of more than one central venous catheter per case in four studies, hematologic malignancy in three studies, catheterization duration in four studies, surgical complexity in four studies, length of ICU stays in three studies, and parenteral nutrition in two studies. Conclusion The decision to place a venous device should be carefully considered by evaluating individual risk factors for the development of CLABSI. This is important due to the potential for severe clinical consequences and significant healthcare expenses associated with this complication. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Alshahrani et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu